ABUS
Arbutus Biopharma Corp
4.20$
-2.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.5 | 6.2 | |
| 12.7 | 91.1 | 159.6 | 106.2 | 42.7 | 26.2 | 23.1 | 34.1 | 77.4 | 35.6 | 38.7 | 25.9 | 14.0 | 31.5 | 9.9 | 16.3 | 40.1 | 48.6 | 40.9 | 34.8 | 42.8 | 35.9 | 20.8 | 12.0 | 8.0 | 9.1 | 14.6 | 16.2 | 15.1 | 23.2 | 35.2 | 57.9 | 109.3 | 101.6 | 104.2 | 38.7 | 59.1 | 65.3 | 4.6 | 5.2 | |
| 0.4 | 0.7 | 0.9 | 1.1 | 2.0 | 1.5 | 1.2 | 1.7 | 2.4 | 1.1 | 1.1 | 0.7 | 1.0 | 2.6 | 0.9 | 1.9 | 2.5 | 3.3 | 2.7 | 2.9 | 3.3 | 2.3 | 2.7 | 2.6 | 2.0 | 2.6 | 3.4 | 2.8 | 2.8 | 4.0 | 4.0 | 4.8 | 6.9 | 6.4 | 8.4 | 7.2 | 11.2 | 12.0 | 3.4 | 3.7 | |
| 11.2 | 87.9 | 148.9 | 102.2 | 42.8 | 23.1 | 22.6 | 33.7 | 75.1 | – | 23.2 | 8.9 | -0.7 | 26.3 | 6.1 | 10.4 | 24.4 | 41.1 | 30.4 | 31.1 | 35.2 | 26.0 | 17.0 | 10.6 | 7.3 | 8.3 | 13.4 | 15.1 | 14.3 | 21.8 | 31.9 | 51.7 | 104.7 | 95.8 | 98.5 | 36.3 | 57.6 | 64.1 | 4.5 | 5.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 5.3 | 6.1 | |
| -34.1% | -45.6% | -39.6% | -31.2% | -18.5% | -19.9% | -20.0% | -15.8% | -11.8% | -32.6% | -32.6% | -54.7% | -88.5% | -37.8% | -104.1% | -49.1% | -20.3% | -15.4% | -17.6% | -20.6% | -14.7% | -17.3% | -6.7% | -8.9% | -13.4% | -10.1% | -17.3% | -21.9% | -25.9% | -20.6% | -17.3% | -12.5% | -9.8% | -10.4% | -8.8% | -10.1% | -5.3% | -4.3% | -3.9% | -2.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -310.5% | -4,008.2% | -5,419.2% | -3,257.3% | -677.9% | -485.8% | -427.3% | -425.9% | -851.2% | -874.5% | -1,031.4% | -1,098.2% | -826.5% | -858.3% | -681.3% | -564.1% | -638.1% | -613.6% | -599.4% | -595.0% | -352.1% | -344.1% | -63.2% | 42.4% | 46.6% | 41.2% | 30.7% | 2.5% | -3.2% | 3.2% | -35.3% | -74.6% | -160.5% | -42.8% | -177.5% | -15.3% | -21.7% | 36.2% | 100.0% | 100.0% | |
| -1,711.4% | -32,973.8% | -43,629.7% | -16,956.2% | -3,865.5% | -1,036.7% | -933.0% | -938.4% | -1,957.4% | -1,510.2% | -1,743.4% | -1,934.2% | -2,436.0% | -2,396.0% | -2,024.0% | -1,701.2% | -887.4% | -836.1% | -800.6% | -788.4% | -678.9% | -669.1% | -320.7% | -192.7% | -177.0% | -167.8% | -217.0% | -323.6% | -359.3% | -430.5% | -616.5% | -827.5% | -1,233.1% | -1,236.7% | -1,430.8% | -444.6% | -379.3% | -348.7% | 80.8% | 81.0% | |
| -1,188.0% | -25,765.5% | -34,453.9% | -14,850.1% | -3,351.9% | -788.9% | -699.2% | -511.1% | -1,099.0% | -959.8% | -1,212.1% | -1,942.3% | -2,426.6% | -2,557.4% | -2,115.4% | -1,758.3% | -1,161.0% | -922.0% | -879.3% | -857.0% | -707.8% | -693.9% | -352.5% | -211.1% | -191.3% | -178.0% | -211.4% | -309.9% | -339.3% | -401.6% | -572.8% | -766.2% | -1,137.6% | -1,133.0% | -1,195.9% | -351.9% | -289.4% | -237.9% | 84.0% | 84.2% | |
| -433.1% | -4,150.3% | -6,323.9% | -3,316.7% | -787.8% | -522.5% | -463.5% | -537.0% | -915.1% | -1,160.7% | -1,260.6% | -1,418.3% | -1,243.3% | -1,191.1% | -1,032.3% | -799.8% | -812.2% | -747.3% | -719.2% | -718.1% | -627.9% | -622.0% | -139.0% | -106.9% | -106.7% | -91.9% | -253.1% | -355.8% | -390.2% | -479.3% | -607.7% | -725.6% | -1,066.8% | -1,053.8% | -922.0% | -391.0% | -310.5% | -281.5% | -17.9% | -13.6% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -41.0% | -189.2% | -204.6% | -156.5% | -159.6% | -46.3% | -35.8% | -26.0% | -34.7% | -28.5% | -34.7% | -54.3% | -176.1% | -211.3% | -197.0% | -206.2% | -73.3% | -62.5% | -58.1% | -71.0% | -55.3% | -45.0% | -45.6% | -46.0% | -47.3% | -50.8% | -48.7% | -54.1% | -63.2% | -68.7% | -64.9% | -63.0% | -71.8% | -71.8% | -96.7% | -65.4% | -54.6% | -43.7% | 61.8% | 59.2% | |
| -33.2% | -139.2% | -144.3% | -107.9% | -111.4% | -35.6% | -30.8% | -22.3% | -30.5% | -25.0% | -30.1% | -46.4% | -125.6% | -145.7% | -140.7% | -138.4% | -54.4% | -46.5% | -45.3% | -52.9% | -43.5% | -37.3% | -31.9% | -32.6% | -33.8% | -35.5% | -36.6% | -41.2% | -47.6% | -50.4% | -49.5% | -48.2% | -54.6% | -53.1% | -65.4% | -52.5% | -43.3% | -35.4% | 58.0% | 55.9% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -22 | -4.7 | -12 | -7.3 | 0.9 | -34 | -5.9 | -4.9 | -16 | – | -80 | -78 | -90 | -31 | -26 | -46 | -97 | -52 | -79 | -31 | -77 | -109 | -81 | -47 | -24 | -30 | -40 | -27 | -17 | -26 | -43 | -62 | -31 | -36 | -37 | -37 | -22 | -17 | -23 | -19 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.1 | -0.1 | |
| 80.9% | 73.6% | 70.5% | 68.9% | 69.8% | 76.9% | 86.1% | 85.9% | 87.7% | 87.9% | 86.6% | 85.4% | 71.3% | 68.9% | 71.4% | 67.1% | 74.3% | 74.4% | 78.1% | 74.5% | 78.6% | 82.9% | 70.0% | 71.0% | 71.4% | 70.0% | 75.3% | 76.2% | 75.2% | 73.4% | 76.3% | 76.5% | 76.1% | 73.9% | 67.6% | 80.4% | 79.2% | 80.9% | 93.9% | 94.4% | |
| 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -3.18 | -7.07 | -7.12 | -5.04 | -4.87 | -1.53 | -1.51 | -1.10 | -1.35 | -1.02 | -1.13 | -1.57 | -2.59 | -2.27 | -2.13 | -1.94 | -0.90 | -0.68 | -0.71 | -0.74 | -0.71 | -0.75 | -0.51 | -0.47 | -0.46 | -0.45 | -0.43 | -0.44 | -0.45 | -0.43 | -0.42 | -0.41 | -0.41 | -0.37 | -0.40 | -0.28 | -0.22 | -0.17 | 0.82 | 0.78 | |
| 0.27 | 0.03 | 0.02 | 0.03 | 0.15 | 0.19 | 0.22 | 0.21 | 0.12 | 0.11 | 0.09 | 0.08 | 0.11 | 0.09 | 0.10 | 0.11 | 0.08 | 0.07 | 0.08 | 0.09 | 0.10 | 0.11 | 0.14 | 0.22 | 0.24 | 0.25 | 0.20 | 0.14 | 0.13 | 0.11 | 0.07 | 0.05 | 0.04 | 0.03 | 0.03 | 0.08 | 0.08 | 0.07 | 0.98 | 0.92 | |
| 7.77 | 3.74 | 3.48 | 3.22 | 3.05 | 3.31 | 4.22 | 4.21 | 3.88 | 3.59 | 3.25 | 2.90 | 1.47 | 1.07 | 1.08 | 0.94 | 1.22 | 1.09 | 1.22 | 1.04 | 1.28 | 1.67 | 1.12 | 1.03 | 0.96 | 0.89 | 0.89 | 0.81 | 0.71 | 0.63 | 0.65 | 0.65 | 0.57 | 0.51 | 0.42 | 0.43 | 0.40 | 0.40 | 1.33 | 1.31 | |
| -1.16 | -1.14 | -1.31 | -1.12 | -1.14 | -1.02 | -1.00 | -1.15 | -1.12 | -1.24 | -1.17 | -1.15 | -1.33 | -1.06 | -1.04 | -0.88 | -0.63 | -0.55 | -0.58 | -0.62 | -0.63 | -0.67 | -0.20 | -0.24 | -0.25 | -0.23 | -0.52 | -0.50 | -0.52 | -0.52 | -0.45 | -0.39 | -0.38 | -0.34 | -0.31 | -0.31 | -0.24 | -0.21 | -0.18 | -0.12 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.